BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21448240)

  • 1. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates.
    Tsai PW; Yang CY; Chang HT; Lan CY
    PLoS One; 2011 Mar; 6(3):e17755. PubMed ID: 21448240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the role of cell-wall β-1,3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37.
    Tsai PW; Yang CY; Chang HT; Lan CY
    PLoS One; 2011; 6(6):e21394. PubMed ID: 21713010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of Candida albicans to the human antimicrobial peptide LL-37.
    Tsai PW; Cheng YL; Hsieh WP; Lan CY
    J Microbiol; 2014 Jul; 52(7):581-9. PubMed ID: 24879350
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hsu CM; Liao YL; Chang CK; Lan CY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638975
    [No Abstract]   [Full Text] [Related]  

  • 5. LL37 and hBD-3 elevate the β-1,3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic.
    Chang HT; Tsai PW; Huang HH; Liu YS; Chien TS; Lan CY
    Biochem J; 2012 Feb; 441(3):963-70. PubMed ID: 22023339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinous Components of Neutrophil Extracellular Traps Are Arrested by the Cell Wall Proteins of
    Karkowska-Kuleta J; Smolarz M; Seweryn-Ozog K; Satala D; Zawrotniak M; Wronowska E; Bochenska O; Kozik A; Nobbs AH; Gogol M; Rapala-Kozik M
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
    Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
    Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the potential of four cathelicidins for the management of mouse candidiasis and Candida albicans biofilms.
    Yu H; Liu X; Wang C; Qiao X; Wu S; Wang H; Feng L; Wang Y
    Biochimie; 2016 Feb; 121():268-77. PubMed ID: 26656137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects on Candida albicans of vagina cells transferred with antimicrobial peptide LL-37 and human defensin 5 recombinant plasmids].
    Wang F; Sun B; Li H; Yin LR
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):205-11. PubMed ID: 22781073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prokaryotic expression and purification of antimicrobial peptide LL-37 and the inhibiting effect against Candida albicans].
    Huo Y; Wang F; Sun B; Yin LR; Zhang PP; Zhang YJ; Zhang BM
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):120-5. PubMed ID: 26917481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection.
    López-García B; Lee PH; Yamasaki K; Gallo RL
    J Invest Dermatol; 2005 Jul; 125(1):108-15. PubMed ID: 15982310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human interleukin 17A enhances the anti-Candida effect of human oral mucosal epithelial cells by inhibiting Candida albicans growth and inducing antimicrobial peptides secretion.
    Jiang L; Fang M; Tao R; Yong X; Wu T
    J Oral Pathol Med; 2020 Apr; 49(4):320-327. PubMed ID: 31145494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.
    Rapala-Kozik M; Bochenska O; Zawrotniak M; Wolak N; Trebacz G; Gogol M; Ostrowska D; Aoki W; Ueda M; Kozik A
    Infect Immun; 2015 Jun; 83(6):2518-30. PubMed ID: 25847962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptide LL-37 and recombinant human mannose-binding lectin express distinct age- and pathogen-specific antimicrobial activity in human newborn cord blood
    Scheid A; Li N; Jeffers C; Borriello F; Joshi S; Ozonoff A; Pettengill M; Levy O
    F1000Res; 2018; 7():616. PubMed ID: 30271580
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial peptide LL-37 disrupts plasma membrane and calcium homeostasis in
    Chen S-Y; Chang C-K; Lan C-Y
    Microbiol Spectr; 2023 Dec; 11(6):e0255123. PubMed ID: 37888991
    [No Abstract]   [Full Text] [Related]  

  • 16. Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.
    De Brucker K; Delattin N; Robijns S; Steenackers H; Verstraeten N; Landuyt B; Luyten W; Schoofs L; Dovgan B; Fröhlich M; Michiels J; Vanderleyden J; Cammue BP; Thevissen K
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5395-404. PubMed ID: 24982087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of antimicrobial peptide LL-37 expressed and purified from prokaryotes in the murine model of vaginal candidiasis].
    Wang F; Huo Y; Yin LR; Sun B; Zhang PP
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):530-4. PubMed ID: 27465873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A heptadeca amino acid peptide subunit of cathelicidin LL-37 has previously unreported antifungal activity.
    Kalimuthu S; Pudipeddi A; Braś G; Tanner JA; Rapala-Kozik M; Leung YY; Neelakantan P
    APMIS; 2023 Nov; 131(11):584-600. PubMed ID: 37150907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging.
    Ordonez SR; Amarullah IH; Wubbolts RW; Veldhuizen EJ; Haagsman HP
    Antimicrob Agents Chemother; 2014; 58(4):2240-8. PubMed ID: 24492359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of
    Lee HS; Kim Y
    J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.